Data / Research funding / North Carolina / Research Triangle Institute
Research Triangle Institute: 176 NIH awards ($1.5B) and 2 NSF awards ($608.3K), fiscal years 2021 to 2026
Research Triangle Institute in Research Triangle Park, NC is funded under 176 NIH awards ($1.5B) and 2 NSF awards ($608.3K) in the NIH and NSF award files, read 2026-11-03. NIH fiscal years 2021 to 2025; NSF fiscal years 2022 to 2026.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- UEI
- JJHCMK4NT5N3
- State
- North Carolina
Awards
178 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| ACTIV Integration of Host-targeting Therapies for COVID-19 Administrative Coordinating Center | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $965,792,899 | June 15, 2020 | June 30, 2026 | THOMAS, SONIA M | reporter.nih.gov |
| Neonatal Research Network Data Coordinating Center (DCC) 2023-2028 | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $29,678,342 | September 1, 2025 | March 31, 2026 | DAS, ABHIK | reporter.nih.gov |
| All of Us Research Program Engagement and Retention Innovators | NIH | Office of the Director, National Institutes of Health | 2021 to 2025 | $28,636,934 | September 10, 2020 | August 31, 2026 | UHRIG, JENNIFER D | reporter.nih.gov |
| Data Coordinating Center (DCC) for the Neonatal Opioid Withdrawal Syndrome Pharmacological Treatments Comparative Effectiveness Trial (NOWS PhaCET) | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $25,628,714 | September 20, 2021 | August 31, 2027 | DAS, ABHIK | reporter.nih.gov |
| Nutrition for Precision Health, powered by the All of Us Research Program: Research Coordinating Center | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2025 | $24,418,322 | July 1, 2025 | November 30, 2025 | GANTZ, MARIE G | reporter.nih.gov |
| BioData Catalyst Data Management Core Program | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $24,042,141 | July 15, 2022 | August 31, 2026 | SIEGE, BRUCE | reporter.nih.gov |
| Chemistry Services for the Division of Translational Toxicology (HIV testing program) | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $21,918,775 | July 30, 2014 | January 31, 2026 | reporter.nih.gov | |
| Chemistry Center for Combatting Antibiotic-Resistant Bacteria (CC4CARB) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $19,637,160 | February 1, 2025 | January 31, 2026 | BLOUGH, BRUCE | reporter.nih.gov |
| Continuation of the NuMoM2b Heart Health Study | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $17,402,772 | February 15, 2020 | January 31, 2027 | MCNEIL, REBECCA BOEHM | reporter.nih.gov |
| NIH Cloud Platform Interoperability Administrative Coordinating Center | NIH | Office of the Director, National Institutes of Health | 2022 to 2023 | $16,914,506 | September 22, 2022 | March 21, 2026 | ROBBINS, ELIZABETH | reporter.nih.gov |
| Pelvic Floor Disorders Network Data Coordinating Center | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $16,166,829 | August 8, 2011 | June 30, 2027 | GANTZ, MARIE G | reporter.nih.gov |
| HEALing Communities Study Health Equity Research | NIH | National Institute on Drug Abuse | 2021 to 2023 | $15,117,207 | April 1, 2019 | September 29, 2024 | OGA, EMMANUEL AJA | reporter.nih.gov |
| CURE SICKLE CELL INITIATIVE DATA STRATEGY AND DATA RESOURCES PROGRAM | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $13,440,748 | September 28, 2018 | December 31, 2026 | KRONER, BARBARA L | reporter.nih.gov |
| Emerging Infectious Diseases Research Centers Coordination Center (EIDRC CC) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $11,018,742 | May 18, 2020 | April 30, 2025 | SEMPOWSKI, GREGORY D | reporter.nih.gov |
| NHLBI CATALYZE PRECLINICAL SERVICES: PROJECTS YR. 4 - TASK ORDER 5 | NIH | National Heart, Lung, and Blood Institute | 2025 | $9,999,898 | September 29, 2025 | September 28, 2026 | JONES, HENDREE E | reporter.nih.gov |
| NHLBI CATALYZE COORDINATING CENTER SUPPORT SERVICES | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $9,914,295 | September 25, 2023 | September 24, 2026 | SEVERYNSE-STEVENS, DIANA | reporter.nih.gov |
| Global Network for Women's and Children's Health Research Data Coordinating Center | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $9,151,864 | July 1, 2017 | June 30, 2030 | MCCLURE, ELIZABETH M | reporter.nih.gov |
| Integrative Omics Center for Accelerating Neurobiological Understanding of Opioid Addiction (ICAN) | NIH | National Institute on Drug Abuse | 2022 to 2025 | $8,995,247 | September 15, 2022 | May 31, 2025 | JOHNSON, ERIC OTTO | reporter.nih.gov |
| NHLBI CATALYZE PROGRAM - PRECLINICAL SERVICES COMPONENT - PROJECTS YEAR 3 | NIH | National Heart, Lung, and Blood Institute | 2024 | $8,628,759 | August 23, 2024 | August 22, 2025 | SEVERYNSE-STEVENS, DIANA M | reporter.nih.gov |
| Coordinating and Data Sharing Center - R&D of Vaccines and Antibodies for Pandemic Preparedness (ReVAMPP) | NIH | National Institute of Allergy and Infectious Diseases | 2024 | $7,994,888 | July 16, 2024 | June 30, 2027 | SEMPOWSKI, GREGORY D | reporter.nih.gov |
| INCLUDE Down Syndrome Clinical Cohort Coordinating Center (DS-4C) | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $7,956,250 | September 20, 2024 | August 31, 2029 | HUNTER, JESSICA EZZELL | reporter.nih.gov |
| Chronic Kidney Diseases of Uncertain Etiology (CKDu) in Agricultural Communities (CURE) Research Consortium - SDCC | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $7,361,594 | August 25, 2021 | June 30, 2028 | LEBOV, JILL | reporter.nih.gov |
| NIMH SYNTHESIS AND DISTRIBUTION OF DRUGS OF ABUSE AND RELATED COMPOUNDS. JUNE 16, 2025 - JUNE 15, 2026. TASK ORDER 75N95025F00002 (TO9). N01DA-22-8944. | NIH | National Institute on Drug Abuse | 2022 to 2025 | $7,184,722 | June 16, 2025 | June 15, 2026 | MASCARELLA, WAYNE | reporter.nih.gov |
| Establishing the PhenX Toolkit as a Biomedical Knowledgebase | NIH | National Human Genome Research Institute | 2022 to 2025 | $7,179,660 | September 20, 2022 | June 30, 2027 | HAMILTON, CAROL MARIE | reporter.nih.gov |
| The Darbepoetin Kindergarten Development Study | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $6,538,886 | September 1, 2023 | August 31, 2028 | BANN, CARLA M | reporter.nih.gov |
| HEAL Research on Interventions for Stability and Engagement (RISE) Network Coordination Center | NIH | National Institute on Drug Abuse | 2024 to 2025 | $5,088,719 | September 30, 2022 | June 30, 2027 | CANCE, JESSICA DUNCAN | reporter.nih.gov |
| HEAL Initiative: Research to Foster an Opioid Use Disorder Treatment System Patients Can Count On | NIH | National Institute on Drug Abuse | 2023 to 2025 | $4,935,947 | September 30, 2023 | August 31, 2028 | MARK, TAMI L | reporter.nih.gov |
| Coordinating Center for the NHLBI Catalyze Program | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $4,324,161 | September 15, 2020 | August 31, 2025 | SEVERYNSE-STEVENS, DIANA M | reporter.nih.gov |
| LA HIV Treatment in Pediatrics | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2024 | $4,291,265 | March 15, 2020 | February 28, 2025 | JOHNSON, LEAH | reporter.nih.gov |
| DMCC for ME/CFS: Recompete 2022 + CDE Admin Supplement | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $4,108,200 | September 25, 2017 | May 31, 2028 | CARNES, MEGAN | reporter.nih.gov |
| Acceptable Multi-user Biodegradable Extended Release (AMBER) Implant System for HIV Prevention | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $3,802,403 | August 20, 2020 | July 31, 2025 | JOHNSON, LEAH | reporter.nih.gov |
| A relationship-focused intervention to reduce intimate partner violence and increase PrEP uptake and adherence among adolescent girls and young women in Kenya | NIH | National Institute of Mental Health | 2021 to 2025 | $3,768,144 | August 19, 2021 | July 31, 2027 | ROBERTS, SARAH TYLER | reporter.nih.gov |
| Human Health Exposure Analysis Resource Core: Untargeted Analysis | NIH | National Institute of Environmental Health Sciences | 2021 to 2025 | $3,588,774 | September 5, 2019 | May 31, 2026 | FENNELL, TIMOTHY RAYMOND | reporter.nih.gov |
| Alcohol Use Disorder Treatment Simulation: Modeling treatment impacts on alcohol-related disparities | NIH | National Institute on Alcohol Abuse and Alcoholism | 2022 to 2025 | $3,328,534 | April 10, 2022 | February 28, 2027 | KARRIKER-JAFFE, KATHERINE J. | reporter.nih.gov |
| NHLBI CATALYZE PROGRAM - PRECLINICAL SERVICES COMPONENT - PROJECTS YEAR 2 | NIH | National Heart, Lung, and Blood Institute | 2023 | $3,234,235 | September 25, 2023 | September 24, 2024 | reporter.nih.gov | |
| Resubmission: Multilevel Strategies & Tailored HIV Prevention & Care for Young Couples who use Alcohol & Other Drugs Across Cape Town | NIH | National Institute on Drug Abuse | 2021 to 2024 | $3,103,589 | July 1, 2020 | May 31, 2026 | BROWNE, FELICIA AMIRA | reporter.nih.gov |
| 2/2 Neonatal Platelet Transfusion Threshold Trial (NeoPlaTT) | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $2,922,467 | May 15, 2024 | April 30, 2031 | DAS, ABHIK | reporter.nih.gov |
| Assessing the Reach, Effectiveness, and Implementation of Multiple Interventions | NIH | National Institute on Drug Abuse | 2022 to 2025 | $2,900,711 | September 30, 2022 | July 31, 2027 | KRAL, ALEXANDER H | reporter.nih.gov |
| Gene Network Identification and Integration (GNetii) Approach to Understanding the Biology Underlying HIV and Drug Abuse. | NIH | National Institute on Drug Abuse | 2021 to 2024 | $2,762,265 | August 1, 2020 | May 31, 2026 | JOHNSON, ERIC OTTO | reporter.nih.gov |
| Opioid Policy Model | NIH | National Institute on Drug Abuse | 2021 to 2024 | $2,750,956 | April 1, 2020 | January 31, 2026 | BOBASHEV, GEORGIY | reporter.nih.gov |
| Transfusion of Prematurity Early School Age Follow-up (TOP 5) DCC | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,727,857 | September 20, 2018 | August 31, 2025 | DAS, ABHIK | reporter.nih.gov |
| TASK ORDER 75N95023F00003 (ACQUISITION, ANALYSIS, TESTING, STORAGE, AND SHIPMENT OF NICOTINE RESEARCH CIGARETTES) UNDER IDIQ NO. 75N95019D00042. | NIH | National Institute on Drug Abuse | 2022 to 2023 | $2,706,674 | September 1, 2023 | November 30, 2024 | MANGUM, KATHERINE | reporter.nih.gov |
| Development of Inhaled CPZEN-45 For Tuberculosis Therapy | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $2,694,338 | March 1, 2019 | February 28, 2025 | SEVERYNSE-STEVENS, DIANA M | reporter.nih.gov |
| NEWBORN SCREENING PILOT STUDIES FOR MUCOPOLYSACCHARIDOSIS TYPE II | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2023 | $2,631,501 | September 28, 2021 | September 27, 2024 | RASPA, MELISSA | reporter.nih.gov |
| Longitudinal examination of emotional reactivity and reactive aggression linking threat exposure with childhood self-injurious thoughts and behaviors | NIH | National Institute of Mental Health | 2023 to 2025 | $2,624,223 | September 1, 2023 | June 30, 2028 | OPPENHEIMER, CAROLINE | reporter.nih.gov |
| Administrative Supplement: Peer Navigators for the ACT NOW OBOE Study | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 | $2,621,089 | September 20, 2019 | June 30, 2024 | BANN, CARLA M | reporter.nih.gov |
| Improving Access to Naloxone to Prevent Opioid Overdose Deaths Within Community-based Programs that Serve People Who Use Drugs | NIH | National Institute on Drug Abuse | 2022 to 2025 | $2,575,705 | September 15, 2022 | June 30, 2027 | LAMBDIN, BARROT HOPKINS | reporter.nih.gov |
| HEAL Initiative: Coordinating Center to Support NIDA Preventing Opioid Use Disorder in Older Adolescents and Young Adults | NIH | National Institute on Drug Abuse | 2024 to 2025 | $2,575,479 | September 30, 2019 | August 31, 2027 | GRAHAM, PHILLIP W | reporter.nih.gov |
| Discovery and development of GPR3 agonists for nicotine cessation | NIH | National Institute on Drug Abuse | 2023 to 2025 | $2,555,113 | September 30, 2023 | July 31, 2028 | GAY, ELAINE ARRINGTON | reporter.nih.gov |
| Social influences on sexual health among Latinx adolescents and emerging adults who identify as LGBTQ+ in an agricultural community | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2024 | $2,500,107 | August 1, 2014 | March 11, 2025 | MINNIS, ALEXANDRA M | reporter.nih.gov |
| Reaching the last 20%: a targeted HIV self-test secondary distribution intervention to engage high-risk men in Kenya | NIH | National Institute of Mental Health | 2022 to 2025 | $2,470,482 | June 6, 2022 | April 30, 2027 | MONTGOMERY, ELIZABETH TRASK | reporter.nih.gov |
| GODDESS (Gathering Online for Dialogue and Discussion to Enhance Social Support): Engaging young African American women in a virtual group app to address alcohol misuse, sexual risk, and PrEP in NC | NIH | National Institute on Alcohol Abuse and Alcoholism | 2022 to 2025 | $2,441,899 | September 1, 2022 | June 30, 2027 | BROWNE, FELICIA AMIRA | reporter.nih.gov |
| Men's Acceptability of Long-acting HIV prevention methods in South Africa | NIH | National Institute of Mental Health | 2021 to 2023 | $2,422,173 | February 14, 2020 | December 31, 2024 | MONTGOMERY, ELIZABETH TRASK | reporter.nih.gov |
| 2/2 Milrinone for Prevention of Post-Patent Ductus Arteriosus Closure Syndrome in Extremely Preterm Infants (MIDAS Trial) - DCC Resubmission | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $2,393,677 | July 1, 2024 | June 30, 2029 | DAS, ABHIK | reporter.nih.gov |
| NHLBI CATALYZE PROGRAM - PRECLINICAL SERVICES COMPONENT - ADMINISTRATIVE SERVICES | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,351,657 | September 30, 2022 | September 29, 2026 | SEVERYNSE-STEVENS, DIANA | reporter.nih.gov |
| Integrating Multiple Omics to Illuminate Gene Networks Underlying Cigarette Smoking and Opioids. | NIH | National Institute on Drug Abuse | 2021 to 2024 | $2,298,081 | September 30, 2020 | June 30, 2026 | HANCOCK, DANA B | reporter.nih.gov |
| Moving beyond the Pain-Suicidality Link: An Investigation of Fluctuations in Social Threat and Neural Response to Social Threat in Momentary Pain and Proximal Risk for Suicidal Ideation in Adolescence | NIH | National Institute of Mental Health | 2023 to 2025 | $2,253,234 | July 1, 2023 | April 30, 2028 | OPPENHEIMER, CAROLINE | reporter.nih.gov |
| Evaluation of Operation Safer Ground: A Community-Level Rapid Housing Intervention for People Vulnerable to COVID-19. | NIH | National Institute on Minority Health and Health Disparities | 2021 to 2024 | $2,231,262 | August 18, 2021 | April 30, 2026 | LORVICK, JENNIFER | reporter.nih.gov |
| Developing/Testing a Multi-level Interventions (SHIELD & IWC) | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2022 | $2,230,356 | September 1, 2018 | August 31, 2024 | SUBRAMANIAN, SUJHA | reporter.nih.gov |
| Long-Acting Prevention Implantable System (LAPIS) for HIV Pre-ExposureProphylaxis (PrEP) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $2,135,154 | March 6, 2020 | February 28, 2025 | JOHNSON, LEAH | reporter.nih.gov |
| Stillbirth Research Consortium Data Coordinating Center | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2025 | $2,072,256 | September 15, 2025 | July 31, 2030 | MCCLURE, ELIZABETH M | reporter.nih.gov |
| HIV Assay Development and Testing to Identify Targeted Activator of Cell Kill Molecules | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,060,112 | August 1, 2024 | September 14, 2026 | MAITRA, RANGAN | reporter.nih.gov |
| NHLBI CATALYZE COORDINATING CENTER - PRODUCT DEVELOPMENT SUPPORT SERVICES, TASK ORDER 4 | NIH | National Heart, Lung, and Blood Institute | 2025 | $1,999,671 | September 29, 2025 | September 28, 2026 | JONES, HENDREE E | reporter.nih.gov |
| Mitochondrial signaling dynamics in cocaine use disorder | NIH | National Institute on Drug Abuse | 2023 to 2025 | $1,977,342 | August 15, 2023 | June 30, 2028 | ABRAHAM, ANTONY DANIEL | reporter.nih.gov |
| NHLBI INNOVATION AND COMMERCIALIZATION ECOSYSTEM DATA SUPPORT, EVALUATION, AND ANALYSIS | NIH | National Heart, Lung, and Blood Institute | 2022 to 2024 | $1,963,635 | March 1, 2024 | September 11, 2024 | SATTERTHWAITE, VIRGINIA | reporter.nih.gov |
| Allosteric Modulation of the CB1 Receptor | NIH | National Institute on Alcohol Abuse and Alcoholism | 2023 to 2025 | $1,940,546 | April 1, 2023 | March 31, 2028 | ZHANG, YANAN | reporter.nih.gov |
| NHLBI CATALYZE COORDINATING CENTER - PRODUCT DEVELOPMENT SUPPORT SERVICES YEAR 2 | NIH | National Heart, Lung, and Blood Institute | 2024 | $1,934,229 | September 13, 2024 | September 12, 2025 | SEVERYNSE-STEVENS, DIANA M | reporter.nih.gov |
| PURITY SPECIFICATIONS, STORAGE, AND DISTRIBUTION FOR MEDICATIONS DEVELOPMENT CONTRACT. JULY 9, 2022 - JULY 8, 2027 | NIH | National Institute on Drug Abuse | 2022 to 2025 | $1,930,643 | July 9, 2022 | July 8, 2025 | RUNYON, SCOTT P | reporter.nih.gov |
| A Prospective Randomized Controlled Trial to Evaluate the Impact of Treatment of Asymptomatic Bacteriuria on Low Birth Weight | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2024 to 2025 | $1,929,206 | September 20, 2024 | August 31, 2028 | MCCLURE, ELIZABETH M | reporter.nih.gov |
| HEAL Initiative: Antenatal Opioid Exposure Longitudinal Study Consortium | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2024 to 2025 | $1,909,404 | September 20, 2019 | June 30, 2027 | BANN, CARLA M | reporter.nih.gov |
| Development of LPA5 Antagonists as Analgesics | NIH | National Institute of Neurological Disorders and Stroke | 2023 | $1,881,741 | July 6, 2023 | June 30, 2025 | ZHANG, YANAN | reporter.nih.gov |
| Genomic Resource Grant for the PhenX Toolkit - expansion and sustainability | NIH | National Human Genome Research Institute | 2021 to 2022 | $1,811,929 | July 1, 2013 | December 31, 2022 | HAMILTON, CAROL MARIE | reporter.nih.gov |
| Multi 'Omics Integration and Neurobiological Signatures of Alcohol Use Disorder | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2023 | $1,750,311 | September 24, 2019 | August 31, 2025 | HANCOCK, DANA B | reporter.nih.gov |
| Task B30: Scale Up Synthesis of VKT-034 | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $1,735,703 | May 2, 2024 | November 1, 2024 | BLOUGH, BRUCE | reporter.nih.gov |
| Methamphetamine injection, associated health risk, and causes of overdose deaths. | NIH | National Institute on Drug Abuse | 2022 to 2024 | $1,714,422 | September 30, 2022 | July 31, 2025 | KRAL, ALEXANDER H | reporter.nih.gov |
| Investigation of Synthetic Cannabinoid Exposures and Pharmacological Consequences | NIH | National Institute on Drug Abuse | 2022 to 2025 | $1,708,678 | April 1, 2016 | May 31, 2028 | MAITRA, RANGAN | reporter.nih.gov |
| Identifying blood-based DNA methylation biomarkers of cannabis use | NIH | National Institute on Drug Abuse | 2021 to 2023 | $1,586,882 | September 30, 2020 | July 31, 2025 | FANG, FANG | reporter.nih.gov |
| Nutritional Omics of Pulmonary Function Decline | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,578,591 | September 23, 2019 | July 31, 2024 | HANCOCK, DANA B | reporter.nih.gov |
| CARES: An adherence support intervention for multiple PREP methods among adolescent girls and young women in South Africa and Zimbabwe | NIH | National Institute of Mental Health | 2024 to 2025 | $1,572,706 | September 11, 2024 | June 30, 2029 | ROBERTS, SARAH TYLER | reporter.nih.gov |
| RTI HEAL Harm Reduction Network Coordination Center | NIH | National Institute on Drug Abuse | 2022 to 2023 | $1,556,321 | September 30, 2022 | June 30, 2027 | OGA, EMMANUEL AJA | reporter.nih.gov |
| Novel therapeutic approach for NASH | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $1,553,952 | June 4, 2020 | May 31, 2025 | MAITRA, RANGAN | reporter.nih.gov |
| Improving Choice and Use of Biomedical HIV Prevention for Women in Uganda: A Couples-Based Approach | NIH | National Institute of Mental Health | 2024 to 2025 | $1,550,745 | September 17, 2024 | June 30, 2028 | MINNIS, ALEXANDRA M | reporter.nih.gov |
| Discovering Small Molecule Biased Agonists for the Neuropeptide S Receptor | NIH | National Institute of Mental Health | 2021 to 2022 | $1,523,350 | December 12, 2019 | October 31, 2023 | RUNYON, SCOTT P | reporter.nih.gov |
| Data Standards to Support Integrated Source to Outcome Modeling | NIH | National Institute of Environmental Health Sciences | 2024 to 2025 | $1,494,995 | June 15, 2024 | April 30, 2029 | HINES, DAVID | reporter.nih.gov |
| Measuring the impact of structural racism and discrimination during adolescence on substance use, psychological distress | NIH | National Institute on Drug Abuse | 2023 to 2025 | $1,486,110 | May 15, 2022 | February 28, 2027 | GOTTFREDSON O'SHEA, NISHA | reporter.nih.gov |
| ANALYTICAL CHEMISTRY AND STABILITY TESTING OF TREATMENT DRUGS FOR SUBSTANCE USE DISORDERS. N01DA-19-8950. PERIOD OF PERFORMANCE: AUGUST 4, 2019 - AUGUST 3, 2024. | NIH | National Institute on Drug Abuse | 2022 to 2023 | $1,410,955 | August 4, 2019 | August 3, 2024 | MANGUM, KATHERINE | reporter.nih.gov |
| Using Omics to Understand the Effects of Drug Abuse on HIV Latent Reservoir | NIH | National Institute on Drug Abuse | 2021 to 2022 | $1,377,622 | August 15, 2018 | May 31, 2025 | JOHNSON, ERIC OTTO | reporter.nih.gov |
| A Growing Crisis of Novel Injection-Related Wounds and Skin & Soft Tissue Infections among People Who Inject Drugs: A Community-Based, Longitudinal Investigation in North Carolina | NIH | National Institute on Drug Abuse | 2024 to 2025 | $1,332,971 | September 30, 2024 | August 31, 2028 | ZIBBELL, JON ERIC | reporter.nih.gov |
| Small molecule antagonist probes for the relaxin-3/RXFP3 system | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2022 | $1,312,747 | September 20, 2020 | December 31, 2024 | JIN, CHUNYANG | reporter.nih.gov |
| In Vivo Probes of Mas1 Receptor | NIH | National Institute of Mental Health | 2024 to 2025 | $1,278,079 | January 12, 2024 | November 30, 2027 | MAITRA, RANGAN | reporter.nih.gov |
| Off-label Use of Rapid Response Fentanyl Test Strips as an Opioid Overdose Prevention Strategy | NIH | National Institute on Drug Abuse | 2021 to 2022 | $1,257,789 | July 1, 2020 | June 30, 2025 | ZIBBELL, JON ERIC | reporter.nih.gov |
| A mixed-methods study of polysubstance use to inform opioid overdose prevention | NIH | National Institute on Drug Abuse | 2021 to 2024 | $1,250,072 | July 15, 2020 | May 31, 2025 | LORVICK, JENNIFER | reporter.nih.gov |
| Clinical progression and predictors of outcomes in congenital Zika syndrome | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2024 to 2025 | $1,248,888 | August 1, 2024 | April 30, 2029 | WHEELER, ANNE CAROLINE | reporter.nih.gov |
| PREPARATION AND DISTRIBUTION OF RESEARCH DRUG PRODUCTS - N01DA-25-8952 | NIH | National Institute on Drug Abuse | 2025 | $1,246,354 | May 15, 2025 | May 14, 2026 | reporter.nih.gov | |
| Integrative Data Analysis of Coping Power: Effects on Adolescent Suicidality | NIH | National Institute of Mental Health | 2021 to 2022 | $1,217,380 | July 1, 2020 | April 30, 2024 | MORGAN-LOPEZ, ANTONIO A | reporter.nih.gov |
| Data Coordinating Center for Sickle Cell Disease Implementation Consortium (SCDIC) | NIH | National Heart, Lung, and Blood Institute | 2021 | $1,191,318 | August 8, 2016 | December 31, 2023 | KRONER, BARBARA L | reporter.nih.gov |
| 2/2 Pomalidomide for Bleeding in Patients with Hereditary Hemorrhagic Telangiectasia (HHT) Bleeding Data Coordinating Center | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,188,232 | March 6, 2019 | February 28, 2026 | THOMAS, SONIA M | reporter.nih.gov |
| LA HIV Treatment in Pediatrics | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $1,045,760 | March 15, 2020 | February 28, 2022 | JOHNSON, LEAH | reporter.nih.gov |
| GPR88 Agonist for Alcoholism Treatment | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2022 | $1,033,134 | September 1, 2018 | July 31, 2025 | JIN, CHUNYANG | reporter.nih.gov |
| Individual Breastfeeding Support with Contingent Incentives for Low-Income Mothers | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2022 | $1,007,036 | August 9, 2018 | May 31, 2025 | WASHIO, YUKIKO | reporter.nih.gov |
| 2/2 Hydrocortisone for BPD Respiratory and Developmental Outcomes Study (HYBRiD Outcomes Study): Data Coordinating Center | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $974,437 | September 1, 2017 | August 31, 2025 | DAS, ABHIK | reporter.nih.gov |
| "A friend in my pocket": mHealth intervention to reduce overdose risk among people who engage in polysubstance use | NIH | National Institute on Drug Abuse | 2024 | $974,317 | September 15, 2024 | August 31, 2026 | LORVICK, JENNIFER | reporter.nih.gov |
| SPECIALIZED ANALYTIC DATA SUPPORT for SEER-MHOS DATA EXPANSIONS | NIH | National Cancer Institute | 2021 to 2025 | $958,402 | September 24, 2021 | September 23, 2026 | BOGGS, ABBEY | reporter.nih.gov |
| NHLBI CATALYZE COORDINATING CENTER - PRODUCT DEVELOPMENT SUPPORT SERVICES | NIH | National Heart, Lung, and Blood Institute | 2023 | $927,396 | September 25, 2023 | September 24, 2024 | reporter.nih.gov | |
| Access to Genetic Information Leveraging Innovative Technology (AGILITY) Study | NIH | National Human Genome Research Institute | 2021 to 2022 | $926,755 | September 22, 2021 | February 29, 2024 | HUNTER, JESSICA EZZELL | reporter.nih.gov |
| Preteen Suicide Risk and Protective Factors Data Coordinating Center | NIH | National Institute of Mental Health | 2024 to 2025 | $915,375 | September 10, 2024 | June 30, 2028 | SAAVEDRA, LISSETTE MARIA | reporter.nih.gov |
| Small molecule modulators of RXFP3 for alcohol use disorder | NIH | National Institute on Alcohol Abuse and Alcoholism | 2025 | $901,666 | September 20, 2025 | June 30, 2030 | JIN, CHUNYANG | reporter.nih.gov |
| Identifying and Disseminating Substance, Treatment, and Strategy (STS) Recommendations to AIDS Service Organizations | NIH | National Institute on Drug Abuse | 2021 | $896,777 | September 15, 2018 | April 30, 2022 | GARNER, BRYAN R | reporter.nih.gov |
| Development and Testing of a Pediatric Anxiety Outcomes Quality Measure (PAO_QM Study) | NIH | National Institute of Mental Health | 2024 to 2025 | $841,292 | September 16, 2024 | March 31, 2028 | MARK, TAMI L | reporter.nih.gov |
| A Multilevel Comprehensive Response on Uptake and Adherence to HIV Prevention Among Adolescent Girls and Young Women | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 | $836,995 | September 18, 2017 | June 30, 2023 | WECHSBERG, WENDEE M | reporter.nih.gov |
| Comparative Pharmacology of Cannabinoids in Rodent Models | NIH | National Institute on Drug Abuse | 2021 to 2022 | $832,915 | April 1, 2018 | December 31, 2025 | MARUSICH, JULIE A | reporter.nih.gov |
| Co-Abuse Cannabis and Tobacco | NIH | National Institute on Drug Abuse | 2021 | $806,275 | September 1, 2017 | July 31, 2024 | MARUSICH, JULIE A | reporter.nih.gov |
| Continued Pressure for Alveolar Protection: A Randomized Controlled Trial (CPAP Trial) | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2025 | $805,722 | August 6, 2025 | July 31, 2030 | DAS, ABHIK | reporter.nih.gov |
| Tropical Medicine Research Centers: TMRC Coordinating Center | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $800,000 | April 15, 2022 | March 31, 2027 | MARLES, NISHA | reporter.nih.gov |
| SUPPORT FOR THE SEER-CAHPS INITIATIVE | NIH | National Cancer Institute | 2021 to 2024 | $784,752 | August 31, 2022 | August 30, 2025 | BOGGS, ABBEY | reporter.nih.gov |
| Master Outreach Small Business Contract | NIH | Office of the Director, National Institutes of Health | 2025 | $784,589 | December 11, 2024 | December 10, 2025 | reporter.nih.gov | |
| Integrated delivery of cancer control interventions for adolescents and young adults living with HIV in Zambia | NIH | National Cancer Institute | 2022 | $779,696 | September 2, 2022 | August 31, 2023 | SUBRAMANIAN, SUJHA | reporter.nih.gov |
| Darbepoetin Trial to Improve Red Cell Mass and Neuroprotection in Preterms - DCC | NIH | National Heart, Lung, and Blood Institute | 2021 | $777,666 | June 1, 2017 | May 31, 2025 | DAS, ABHIK | reporter.nih.gov |
| Harnessing Knowledge of Gene Function in Brain Tissue for Discovering Biology Underlying Heroin Addiction | NIH | National Institute on Drug Abuse | 2021 | $774,951 | May 1, 2017 | February 28, 2023 | JOHNSON, ERIC OTTO | reporter.nih.gov |
| Adapting and Piloting Behavioral Activation for Veterans with Co-Occurring AUD and Posttraumatic Stress Disorder | NIH | National Institute on Alcohol Abuse and Alcoholism | 2023 to 2025 | $747,807 | May 10, 2023 | April 30, 2026 | BLAKEY, SHANNON MICHELLE | reporter.nih.gov |
| Mitigating the Outcomes Associated with the Injection Drug Use Epidemic in Southern Appalachia | NIH | National Institute on Drug Abuse | 2021 | $732,149 | August 15, 2017 | July 31, 2024 | ZULE, WILLIAM A | reporter.nih.gov |
| Type 1 Hybrid Implementation Effectiveness Cluster Randomized Trial of an mHealth Intervention to Help Parents Prevent Early Onset Alcohol Use. | NIH | National Institute on Alcohol Abuse and Alcoholism | 2025 | $711,938 | September 20, 2025 | August 31, 2030 | GOTTFREDSON O'SHEA, NISHA | reporter.nih.gov |
| The Rhode Island Children’s Health Equity and Development Study (ENRICHED) COHORT 1: CLOSEOUT ACTIVITIES | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2023 | $694,703 | March 1, 2023 | September 29, 2023 | GUYER, HEIDI | reporter.nih.gov |
| Preventing Overdose and Promoting Recovery through Court Navigation | NIH | National Institute on Drug Abuse | 2025 | $661,850 | September 30, 2025 | May 31, 2030 | RAY, BRADLEY | reporter.nih.gov |
| Pathways to Treatment: Assessing Effectiveness and Implementation of Oregon's Deflection Programs for People who Use Drugs | NIH | National Institute on Drug Abuse | 2025 | $643,285 | September 15, 2025 | May 31, 2030 | SMILEY-MCDONALD, HOPE MARIE | reporter.nih.gov |
| The Substance Abuse Treatment to HIV care (SAT2HIV-II) Project | NIH | National Institute on Drug Abuse | 2021 | $613,082 | July 15, 2020 | April 30, 2022 | GARNER, BRYAN R | reporter.nih.gov |
| Fabrication of Nanoscale Plastics and Effects on Intestinal Barrier Function In Vitro | NIH | National Institute of Environmental Health Sciences | 2022 to 2023 | $607,832 | August 1, 2022 | July 31, 2025 | FENNELL, TIMOTHY RAYMOND | reporter.nih.gov |
| Development of GPR139 antagonists for the treatment of pain | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $603,406 | May 9, 2025 | April 30, 2027 | JIN, CHUNYANG | reporter.nih.gov |
| PURITY SPECIFICATIONS, STORAGE AND DISTRIBUTION FOR MEDICATIONS DEVELOPMENT. JULY 9, 2017 - JULY 8, 2020. N01DA-17-8934. | NIH | National Institute on Drug Abuse | 2021 to 2022 | $591,950 | July 9, 2017 | July 8, 2022 | MANGUM, KATHERINE | reporter.nih.gov |
| Minor Cannabinoids and Terpenes: Preclinical Evaluation as Analgesics | NIH | National Center for Complementary & Integrative Health | 2021 to 2023 | $560,920 | September 15, 2019 | October 31, 2023 | GAMAGE, THOMAS F | reporter.nih.gov |
| Multi-omic Data Integration and Translational Insights for Alcohol Use Disorder with and Without Cigarette Smoking | NIH | National Institute on Alcohol Abuse and Alcoholism | 2025 | $559,180 | September 1, 2025 | June 30, 2030 | WHITE, JULIE DANIELLE | reporter.nih.gov |
| NIDDK Implementation of NIH Data Management and Sharing Policy consultancy project | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2023 | $555,648 | July 21, 2022 | July 20, 2023 | ALLSUP, TIM | reporter.nih.gov |
| Optimization and Characterization of Small Molecule GPR17 Antagonists for Multiple Sclerosis | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $547,846 | August 1, 2025 | July 31, 2027 | NARAYANAN, SANJU | reporter.nih.gov |
| EOI::IMPLEMENTING THE PRESIDENT'S DEPARTMENT OF GOVERNMENT EFFICIENCY COST EFFICIENCY INITIATIVE (MARCH 19, 2025)::EOI ACST OF TREATMENT DRUGS FOR SUBSTANCE USE DISORDERS. N01DA-19-8950. PERIOD OF PE | NIH | National Institute on Drug Abuse | 2025 | $543,704 | August 4, 2024 | August 3, 2026 | reporter.nih.gov | |
| Child and Family Consequences of Congenital Zika Syndrome in Brazil | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 | $535,760 | August 17, 2017 | April 30, 2023 | BAILEY, DONALD B | reporter.nih.gov |
| Adapting and testing a behavioral intervention to prevent FASD and adverse infant outcomes | NIH | National Institute on Alcohol Abuse and Alcoholism | 2025 | $523,143 | September 22, 2022 | August 31, 2028 | WASHIO, YUKIKO | reporter.nih.gov |
| APJ receptor agonism for metabolic syndrome | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 | $486,222 | April 1, 2017 | October 1, 2024 | MAITRA, RANGAN | reporter.nih.gov |
| Improving the Integration of Mental Health and Substance Use Treatment into Ryan White-Funded Care Sites in Atlanta using an Implementation Science Approach | NIH | National Institute of Mental Health | 2021 to 2022 | $485,155 | July 15, 2020 | June 30, 2024 | BONNER, COURTNEY PEASANT | reporter.nih.gov |
| Innovating Measurement of Youth Social Media Activity: An Approach for Using a Large Language-Based Computer Vision Model to Study What Youth Are Doing on Social Media and Links to Mental Health | NIH | National Institute of Mental Health | 2025 | $460,693 | September 1, 2025 | August 31, 2027 | OPPENHEIMER, CAROLINE | reporter.nih.gov |
| STRIDES (Strategies To Reduce Intersectional Drug usE Stigma): A mixed-methods, human-centered approach to address barriers to HIV services | NIH | National Institute on Drug Abuse | 2021 to 2022 | $460,398 | May 1, 2021 | August 31, 2025 | BROWNE, FELICIA AMIRA | reporter.nih.gov |
| Improving accessibility of virtual interventions for families of infants with neurogenetic conditions - Resubmission | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2024 to 2025 | $451,742 | July 11, 2024 | June 30, 2026 | WHEELER, ANNE CAROLINE | reporter.nih.gov |
| Coordinating Center for Research Centers for Improving Management of Symptoms During and Following Cancer Treatment | NIH | National Cancer Institute | 2023 | $451,000 | May 1, 2023 | February 28, 2025 | ARDINI, MARY-ANNE | reporter.nih.gov |
| Meta-analysis of Individual Patient Data for PTSD/AODs | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 | $439,238 | June 1, 2018 | May 31, 2023 | MORGAN-LOPEZ, ANTONIO A | reporter.nih.gov |
| Adapting and testing a behavioral intervention to prevent FASD and adverse infant outcomes | NIH | National Institute on Alcohol Abuse and Alcoholism | 2022 to 2023 | $436,054 | September 20, 2022 | August 31, 2024 | WASHIO, YUKIKO | reporter.nih.gov |
| Stress and HIV infection in South African adolescent girls. | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2022 | $435,938 | September 1, 2021 | August 31, 2024 | STONER, MARIE | reporter.nih.gov |
| Community-engaged environmental monitoring for biowaste treatment transitions | NIH | National Institute of Environmental Health Sciences | 2023 | $417,878 | July 19, 2023 | June 30, 2025 | CHO, SEUNG-HYUN | reporter.nih.gov |
| Adapting machine learning methods to detect genetic loci specific to strictly defined MDD | NIH | National Institute of Mental Health | 2021 to 2022 | $416,778 | April 1, 2021 | March 31, 2024 | WEBB, BRADLEY TODD | reporter.nih.gov |
| Preventing Intimate Partner Violence Among Teens Who Are Pregnant or Parenting | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2024 to 2025 | $415,746 | August 19, 2024 | July 31, 2026 | KAN, MARNI L | reporter.nih.gov |
| Gene Selection for Newborn Sequencing Studies | NIH | National Human Genome Research Institute | 2024 | $415,712 | September 19, 2024 | August 31, 2026 | PEAY, HOLLY LANDRUM | reporter.nih.gov |
| Community Mitigation Against Xylazine | NIH | National Institute on Drug Abuse | 2024 to 2025 | $405,578 | September 1, 2024 | August 31, 2027 | RAY, BRADLEY | reporter.nih.gov |
| SYNTHESIS AND DISTRIBUTION OF DRUGS OF ABUSE AND RELATED COMPOUNDS. N01DA-18-8944. PERIOD OF PERFORMANCE: JUNE 9, 2018 - JUNE 8, 2022 | NIH | National Institute on Drug Abuse | 2021 | $397,205 | June 1, 2020 | May 31, 2021 | JAMES, HAYES | reporter.nih.gov |
| Growing Xylazine Supply in NC: A Community-Based Investigation of Exposure and Health Consequences | NIH | National Institute on Drug Abuse | 2024 to 2025 | $381,191 | July 15, 2024 | June 30, 2026 | ZIBBELL, JON ERIC | reporter.nih.gov |
| Capturing and characterizing variability of cognition and behavior in Down syndrome | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 | $349,920 | November 1, 2021 | August 31, 2024 | HUNTER, JESSICA EZZELL | reporter.nih.gov |
| DATA ANALYTICS, STATISTICAL AND BIOINFORMATIC ANALYSIS AND TOOL DEVELOPMENT, Genome wide association studies (GWAS) | NIH | National Cancer Institute | 2023 to 2025 | $348,000 | September 16, 2023 | September 15, 2025 | GADDIS, NATHAN | reporter.nih.gov |
| Mobile behavioral intervention to reduce maternal drinking in South Africa | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2022 | $347,005 | March 5, 2021 | February 29, 2024 | WASHIO, YUKIKO | reporter.nih.gov |
| Understanding and measuring the impact of stigma on PrEP adherence among adolescent girls and young women in Kenya: identifying targets for future interventions | NIH | Fogarty International Center | 2021 | $328,671 | August 1, 2020 | June 30, 2022 | ROBERTS, SARAH TYLER | reporter.nih.gov |
| Improving HIV treatment outcomes for people who use drugs: adapting and piloting a drug-use use stigma-reduction intervention in HIV care and treatment clinics in Tanzania | NIH | Fogarty International Center | 2021 | $321,312 | August 1, 2020 | June 30, 2023 | NYBLADE, LAURA | reporter.nih.gov |
| Collaborative Research: Unintended Consequences of Law Enforcement Disruptions to Illicit Drug Networks | NSF | Division of Social and Economic Sciences | 2022 | $308,264 | August 1, 2022 | July 31, 2026 | Bradley R Ray | nsf.gov |
| EAGER: PBI: Designing Public Use Microdata Business Areas (PUMBAs) for Innovation | NSF | Regional Innovation Section | 2024 | $299,999 | October 1, 2024 | September 30, 2026 | Jennifer K Ozawa | nsf.gov |
| Improving Models of Alcohol Consumption Mismeasurement and Burden of Disease | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 | $258,390 | September 5, 2019 | August 31, 2023 | ALDRIDGE, ARNIE PAUL | reporter.nih.gov |
| Pediatric Preclinical Testing Consortium: Coordinating Center-Additional PPTC funding extension | NIH | National Cancer Institute | 2021 | $251,499 | November 14, 2020 | June 30, 2021 | GATTO, GREGORY J | reporter.nih.gov |
| Identification of small molecule NPBWR1 agonists | NIH | National Institute on Drug Abuse | 2023 to 2024 | $233,969 | August 15, 2023 | July 31, 2025 | NGUYEN, THUY | reporter.nih.gov |
| Innovative Personal Monitoring Approaches to Characterize Ultrafine and Fine Particulate Matter and Respiratory Health Effects | NIH | National Institute of Environmental Health Sciences | 2021 | $231,615 | May 19, 2020 | December 31, 2023 | CHO, SEUNG-HYUN | reporter.nih.gov |
| Optimization of Small Molecule GPR17 Antagonists for Multiple Sclerosis | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $217,601 | March 15, 2021 | February 29, 2024 | NARAYANAN, SANJU | reporter.nih.gov |
| Assay development for characterization of Adrb3 antagonists as pain therapeutics | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $196,439 | July 1, 2021 | December 31, 2023 | GAY, ELAINE ARRINGTON | reporter.nih.gov |
| SURVEY COLLECTION AND ANALYSIS REGARDING COVID-19 DRIVEN DRINKING HABITS | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 | $194,513 | November 4, 2020 | July 3, 2021 | BARBOSA, CAROLINA | reporter.nih.gov |
| Determining minimal clinically important differences for neurodevelopmental outcome measures in Angelman syndrome | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2022 | $180,610 | May 1, 2021 | April 30, 2024 | WHEELER, ANNE CAROLINE | reporter.nih.gov |
| In vitro and in vivo characterization of CB1 allosteric modulators | NIH | National Institute on Drug Abuse | 2021 to 2022 | $177,423 | July 15, 2018 | August 11, 2023 | GAMAGE, THOMAS F | reporter.nih.gov |
| An integrated community-clinic model of optimized implementation strategies to increase early detection of breast and cervical cancers in Kenya | NIH | National Cancer Institute | 2023 | $145,983 | February 1, 2023 | July 31, 2023 | SUBRAMANIAN, SUJHA | reporter.nih.gov |
| Identification of small molecule orexin agonists | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $107,279 | March 13, 2025 | February 28, 2027 | ZHANG, YANAN | reporter.nih.gov |
| IGF::OT::IGF - RTI INTERNATIONAL TO PROVIDE SUPPORT SERVICES FOR FUNCTIONAL AREA TWO (2) OF THE NHLBI INNOVATION AND COMMERCIALIZATION COORDINATING CENTER (NIC3) FOR A PERIOD OF PERFORMANCE OF MAY 1, | NIH | National Heart, Lung, and Blood Institute | 2021 | $100,000 | May 1, 2015 | August 31, 2021 | WOOTEN, LINDA | reporter.nih.gov |
| EVALUATION AND TESTING SERVICES (ETS) FOR VACCINES AND OTHER BIOLOGICS FOR INFECTIOUS DISEASES | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $10,000 | September 30, 2025 | September 29, 2035 | SOMARA, SITA | reporter.nih.gov |
| Preclinical Services for Biopharmaceutical Product Development | NIH | National Institute of Allergy and Infectious Diseases | 2023 | $5,178 | September 8, 2023 | September 7, 2030 | reporter.nih.gov | |
| Virtual Kick off Meeting with NCI for MAS Synthesis Pool | NIH | National Cancer Institute | 2023 | $3,127 | April 11, 2023 | May 11, 2023 | reporter.nih.gov | |
| Interventional Agents Safety and Pharmacokinetic Services | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $1,094 | September 25, 2025 | September 24, 2026 | reporter.nih.gov | |
| Interventional Agents Chemistry Services | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $1,000 | September 25, 2025 | September 24, 2026 | reporter.nih.gov | |
| Chemical Compound Storage | NIH | National Institute on Drug Abuse | 2022 | $838 | May 27, 2022 | June 15, 2022 | reporter.nih.gov | |
| Disparate Exposures, Disparate Outcomes: The Effect of Cumulative Disadvantage | NIH | National Institute on Minority Health and Health Disparities | 2021 | $1 | September 27, 2016 | August 21, 2021 | BRAVO, MERCEDES AURELIA | reporter.nih.gov |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 79 | $112,677,900 | 0 | $0 |
| 2024 | 79 | $396,921,298 | 1 | $299,999 |
| 2023 | 78 | $550,542,351 | 0 | $0 |
| 2022 | 82 | $313,263,107 | 1 | $308,264 |
| 2021 | 85 | $151,989,922 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
Topics of its NIH awards
- Clinical Research
- Prevention
- Behavioral and Social Science
- Substance Misuse
- Pediatric
- Clinical Trials and Supportive Activities
- Brain Disorders
- Drug Abuse (NIDA only)
- Translational Research
- Infectious Diseases
- Social Determinants of Health
- Neurosciences
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.